- Home
- CHN vs BTMD Comparison
CHN vs BTMD Comparison
Compare CHN & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHN
- BTMD
- Stock Information
- Founded
- CHN 1992
- BTMD 2012
- Country
- CHN United States
- BTMD United States
- Employees
- CHN N/A
- BTMD N/A
- Industry
- CHN Investment Managers
- BTMD Medicinal Chemicals and Botanical Products
- Sector
- CHN Finance
- BTMD Health Care
- Exchange
- CHN Nasdaq
- BTMD Nasdaq
- Market Cap
- CHN 144.1M
- BTMD 129.1M
- IPO Year
- CHN N/A
- BTMD N/A
- Fundamental
- Price
- CHN $14.97
- BTMD $4.08
- Analyst Decision
- CHN
- BTMD Strong Buy
- Analyst Count
- CHN 0
- BTMD 1
- Target Price
- CHN N/A
- BTMD $8.00
- AVG Volume (30 Days)
- CHN 31.8K
- BTMD 125.4K
- Earning Date
- CHN 01-01-0001
- BTMD 08-07-2025
- Dividend Yield
- CHN 0.19%
- BTMD N/A
- EPS Growth
- CHN N/A
- BTMD 201.68
- EPS
- CHN N/A
- BTMD 0.60
- Revenue
- CHN N/A
- BTMD $199,379,000.00
- Revenue This Year
- CHN N/A
- BTMD $5.87
- Revenue Next Year
- CHN N/A
- BTMD $8.59
- P/E Ratio
- CHN N/A
- BTMD $6.80
- Revenue Growth
- CHN N/A
- BTMD 6.44
- 52 Week Low
- CHN $9.00
- BTMD $3.04
- 52 Week High
- CHN $12.98
- BTMD $8.44
- Technical
- Relative Strength Index (RSI)
- CHN 74.35
- BTMD 52.38
- Support Level
- CHN $14.69
- BTMD $3.92
- Resistance Level
- CHN $14.88
- BTMD $4.36
- Average True Range (ATR)
- CHN 0.21
- BTMD 0.20
- MACD
- CHN 0.00
- BTMD -0.01
- Stochastic Oscillator
- CHN 96.30
- BTMD 36.00
About CHN China Fund Inc. (The)
CHINA FUND INC is a non-diversified, closed-end management investment company. Its investment objective is a long-term capital appreciation which it seeks to achieve by investing in equity securities with trading in China and outside China. It invests in various industries such as Insurance, Entertainment, Machinery, Electrical Equipment, Beverages, Hotels, Restaurants, and Leisure among others.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.